Literature DB >> 1903190

Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats.

J K Rowlett1, B A Mattingly, M T Bardo.   

Abstract

In three experiments, rats were injected once daily with 5.0 mg/kg apomorphine or vehicle and tested for locomotor activity for 10-14 days. In each experiment, apomorphine produced behavioral sensitization, characterized by a progressively greater increase in locomotor activity with each succeeding injection. On day 11 of testing, in an experiment designed to assess the synthesis of dopamine (DA), rats were injected with 5.0 mg/kg apomorphine or vehicle, followed by 100 mg/kg NSD-1015, an inhibitor of the enzyme l-aromatic amino acid decarboxylase. After administration of NSD-1015, concentrations of dihydroxyphenylalanine (DOPA) were determined in striatal and mesolimbic tissues by high performance liquid chromatography (HPLC) with electrochemical detection. The results revealed a significant decrease in accumulation of DOPA in both striatal and mesolimbic tissue after acute treatment with apomorphine. More important, chronic treatment with apomorphine produced a significant increase in accumulation of DOPA in both areas. In subsequent experiments, rats on day 14 of testing were sacrificed for determination of levels of DA, 3,4-dihydroxyphenylacetic acid (DOPAC) or specific binding of [3H]spiperone in the striatum and mesolimbic region. Although levels of DOPAC were significantly reduced in the regions of the brain after an acute injection of apomorphine, chronic treatment with apomorphine did not significantly affect levels of DA, DOPAC or specific binding of [3H]spiperone. These findings suggest that the development of behavioral sensitization to apomorphine may be related to an alteration in the synthesis of DA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903190     DOI: 10.1016/0028-3908(91)90203-n

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.

Authors:  B A Mattingly; J K Rowlett; J T Graff; B J Hatton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine.

Authors:  B A Mattingly; S E Fields; M S Langfels; J K Rowlett; P M Robinet; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

3.  Sensitivity to apomorphine-induced yawning and hypothermia in rats eating standard or high-fat chow.

Authors:  Michelle G Baladi; Yvonne M Thomas; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2011-12-30       Impact factor: 4.530

4.  Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists.

Authors:  S A McDougall; M A Duke; C A Bolanos; C A Crawford
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  An interface for sensitive analysis of monoamine neurotransmitters by ion-pair chromatography-electrospray ionization-mass spectrometry with continuous online elimination of ion-pair reagents.

Authors:  Shuyun Shi; Binqing Zhao; Gargey Yagnik; Feimeng Zhou
Journal:  Anal Chem       Date:  2013-07-02       Impact factor: 6.986

7.  Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.

Authors:  B A Mattingly; J K Rowlett; G Lovell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

9.  Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.

Authors:  S Jauhar; M Veronese; M Rogdaki; M Bloomfield; S Natesan; F Turkheimer; S Kapur; O D Howes
Journal:  Transl Psychiatry       Date:  2017-02-07       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.